Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure (Q44123394)

30 November 2017

Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure (English)

1 reference

30 November 2017

0 references

chronic heart failure

1 reference

9

Jean L Rouleau

1 reference

30 November 2017

Tej Sheth

1

1 reference

30 November 2017

Tom Parker

2

1 reference

30 November 2017

Alan Block

3

1 reference

30 November 2017

Christian Hall

4

1 reference

30 November 2017

Albert Adam

5

1 reference

30 November 2017

Mark A Pfeffer

6

1 reference

30 November 2017

Duncan J Stewart

7

1 reference

30 November 2017

Chunlin Qian

8

1 reference

30 November 2017

IMPRESS Investigators

10

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

American Journal of Cardiology

30 November 2017

1 reference

30 November 2017

90

1 reference

30 November 2017

5

1 reference

30 November 2017

496-500

1 reference

Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Activation of neurohumoral systems in postinfarction left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

The natriuretic-peptide family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Endothelin in human congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902521-3

10.1016/S0002-9149(02)02521-3

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference